Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

J&J companies will collaborate on development of Maxia compounds for type 2 diabetes

Jan. 4, 2001

Replagal BLA deemed not approvable by FDA; further data requested

Jan. 4, 2001

Case-control study identifies association between phenylpropanolamine and hemorrhagic stroke

Jan. 4, 2001

Review of Aventis Behring's Rx for inherited emphysema to be fast-tracked by FDA

Jan. 4, 2001

TKT to commence clinical trials of Hunter's syndrome treatment

Jan. 3, 2001

Update on status of Fabrazyme reported by Genzyme General

Jan. 3, 2001

IND filed to investigate Hemolink in chemotherapy-associated anemia

Jan. 3, 2001

Inhibitors of PTP1B and their use covered in patent issued to Merck Frosst

Jan. 2, 2001

Glucagon antagonists jointly claimed by Novo Nordisk and Agouron

Dec. 29, 2000

Schering AG's Mirena approved by FDA

Dec. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...